Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Johnson & Johnson JNJ

Healthcare  —  Drug Manufacturers General
271.22 0.54 0.20% as of 25 Sep
Market cap
$652.8B
P/E
31.4×
S&P 500 Member Dividend Aristocrat Cash Flow Champion (3y) Revenue Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Johnson & Johnson (JNJ) P/E ratio

As of 25 September 2026, Johnson & Johnson (JNJ) trades at a P/E ratio of 31.4×. Over the past ten years it has ranged from 9.5× (May 2024) to 380× (January 2018); the current reading is higher than 87% of that period. That is above the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 18.7× (24.87%)
FY2024 24.9× 115.20%
FY2023 11.6× (56.19%)
FY2022 26.4× 20.70%
FY2021 21.9× (23.31%)
FY2020 28.6× 10.34%
FY2019 25.9× 12.53%
FY2018 23.0× (93.56%)
FY2017 357× 1,712.12%
FY2016 19.7× 5.29%

Quarterly

Period P/E ratio Change
Jun 2026 29.4× 4.14%
Mar 2026 28.3× 50.89%
Dec 2025 18.7× 4.64%
Sep 2025 17.9× 9.55%
42 more quarters

Against its own ten years

Low 9.5× High 380×
Ten-year median 23.3×
Current reading's percentile 87

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
JNJ Johnson & Johnson 31.4×
PFE Pfizer Inc. compare 37.7×
LLY Eli Lilly and Company compare 39.7×
ABBV AbbVie Inc. compare 74.7×
MRK Merck & Co., Inc. compare 119×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on JNJ